ATE454899T1 - Leptin zur behandlung des respiratory-distress- syndroms und verminderter lungen surfactant- produktion - Google Patents

Leptin zur behandlung des respiratory-distress- syndroms und verminderter lungen surfactant- produktion

Info

Publication number
ATE454899T1
ATE454899T1 AT01273694T AT01273694T ATE454899T1 AT E454899 T1 ATE454899 T1 AT E454899T1 AT 01273694 T AT01273694 T AT 01273694T AT 01273694 T AT01273694 T AT 01273694T AT E454899 T1 ATE454899 T1 AT E454899T1
Authority
AT
Austria
Prior art keywords
treatment
leptin
surfactant production
respiratory distress
distress syndrome
Prior art date
Application number
AT01273694T
Other languages
English (en)
Inventor
Vicky Funanage
Sandra Hassink
Susan Kirwin
Darlise Connor
Original Assignee
Nemours Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nemours Foundation filed Critical Nemours Foundation
Application granted granted Critical
Publication of ATE454899T1 publication Critical patent/ATE454899T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fluid-Pressure Circuits (AREA)
  • Medicinal Preparation (AREA)
AT01273694T 2000-11-14 2001-11-13 Leptin zur behandlung des respiratory-distress- syndroms und verminderter lungen surfactant- produktion ATE454899T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/711,295 US6884777B1 (en) 2000-11-14 2000-11-14 Method for treating respiratory distress syndrome
PCT/US2001/043069 WO2002062289A2 (en) 2000-11-14 2001-11-13 Method for treating respiratory distress syndrome

Publications (1)

Publication Number Publication Date
ATE454899T1 true ATE454899T1 (de) 2010-01-15

Family

ID=24857494

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01273694T ATE454899T1 (de) 2000-11-14 2001-11-13 Leptin zur behandlung des respiratory-distress- syndroms und verminderter lungen surfactant- produktion

Country Status (7)

Country Link
US (2) US6884777B1 (de)
EP (1) EP1341550B1 (de)
AT (1) ATE454899T1 (de)
AU (1) AU2001297652A1 (de)
CA (1) CA2428937C (de)
DE (1) DE60141083D1 (de)
WO (1) WO2002062289A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475984B2 (en) * 1999-04-29 2002-11-05 The Nemours Foundation Administration of leptin
US6884777B1 (en) * 2000-11-14 2005-04-26 The Nemours Foundation Method for treating respiratory distress syndrome
SI1841458T1 (sl) * 2005-01-06 2012-04-30 Discovery Lab Inc Zdravljenje s predpisanim odmerjanjem surfaktanta za zdravljenje ali preprečevanje bronhopulmonalne displazije
ES2258923B1 (es) * 2005-02-23 2007-11-01 Universitat De Les Illes Balears Uso de la leptina para la prevencion del exceso de peso corporal y composicion que contiene leptina.
RU2523573C1 (ru) * 2013-04-23 2014-07-20 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский институт акушерства и педиатрии" Министерства здравоохранения Российской Федерации Способ лечения респираторного дистресс-синдрома новорожденных, находящихся на ивл
WO2014193597A1 (en) * 2013-05-02 2014-12-04 University Of Vermont And State Agricultural College Leptin for treating systemic inflammatory response syndrome

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048837A (en) * 1994-08-17 2000-04-11 The Rockefeller University OB polypeptides as modulators of body weight
US5552523A (en) 1995-01-31 1996-09-03 Eli Lilly And Company Anti-obesity proteins
US5521283A (en) 1995-01-31 1996-05-28 Eli Lilly And Company Anti-obesity proteins
US5552522A (en) 1995-01-31 1996-09-03 Eli Lilly And Company Anti-obesity proteins
US5552524A (en) 1995-01-31 1996-09-03 Eli Lilly And Company Anti-obesity proteins
WO1997015322A1 (en) 1995-10-25 1997-05-01 The Regents Of The University Of California Methods for restoring or enhancing reproductive function in reproductively impaired hosts
US6022737A (en) 1995-11-02 2000-02-08 Amgen Inc. Formulations for non-viral in vivo transfection in the lungs
US5854067A (en) 1996-01-19 1998-12-29 Board Of Regents, The University Of Texas System Hexokinase inhibitors
US5891717A (en) 1996-01-19 1999-04-06 Betagene, Inc. Methods and compositions for inhibiting hexokinase
US5847008A (en) 1996-02-02 1998-12-08 Merck & Co., Inc. Method of treating diabetes and related disease states
US6020382A (en) 1996-02-02 2000-02-01 Merck & Co., Inc. Method of treating diabetes and related disease states
US5859051A (en) 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
US5866341A (en) 1996-04-03 1999-02-02 Chugai Pharmaceutical Co., Ltd. Compositions and methods for screening drug libraries
US5728728A (en) 1996-04-10 1998-03-17 Kozachuk; Walter E. Methods of providing neuroprotection
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
GB9726851D0 (en) 1997-12-19 1998-02-18 Zeneca Ltd Human signal transduction serine/threonine kinase
US6475984B2 (en) 1999-04-29 2002-11-05 The Nemours Foundation Administration of leptin
US6630444B1 (en) * 2000-10-23 2003-10-07 The Nemours Foundation Intestinal function using leptin
US6884777B1 (en) * 2000-11-14 2005-04-26 The Nemours Foundation Method for treating respiratory distress syndrome

Also Published As

Publication number Publication date
EP1341550A2 (de) 2003-09-10
DE60141083D1 (de) 2010-03-04
WO2002062289A3 (en) 2002-11-28
CA2428937C (en) 2011-01-25
EP1341550A4 (de) 2004-07-07
CA2428937A1 (en) 2002-08-15
US6884777B1 (en) 2005-04-26
AU2001297652A1 (en) 2002-08-19
US20060084601A1 (en) 2006-04-20
WO2002062289A2 (en) 2002-08-15
EP1341550B1 (de) 2010-01-13

Similar Documents

Publication Publication Date Title
NO20031471L (no) Glykoformer av faktor VII
ATE324110T1 (de) Stoffe mit serotoninartiger wirkung zur behandlung der schlafapnoe
DE60231804D1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomöostase störungen
DE60139554D1 (de) Probiotika zur primären prävention atopischer erkrankungen
DE60119534D1 (de) Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
DE60213861D1 (de) Orodispergierbare tabletten mit fexofenadin
ATE417606T1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
ATE463247T1 (de) Bupropion metaboliten zur behandlung von angstzuständen
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
WO2005018535A3 (en) Compositions and methods for treatment of severe acute respiratory syndrome (sars)
DE60234246D1 (de) Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen
DE60017801D1 (de) Inhalierung von antiendotoxinmitteln zur vorbeugung oder behandlung von bakterieller lungeninfektion oder symptomatischer endotoxinaussetzung der lunge
DE50109156D1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
EP1305042A4 (de) Zusammensetzungen und methoden zur behandlung von schleimhautinfektionen
DE50212760D1 (de) Ermittlung des patientenbezogenen Kariesrisikos
ATE454899T1 (de) Leptin zur behandlung des respiratory-distress- syndroms und verminderter lungen surfactant- produktion
DE602005024571D1 (de) Opioide zur behandlung von ruhelosigkeit in den unteren gliedmassen
SE0401631L (sv) Ny sammansättning
DE60128009D1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE306271T1 (de) Kombination von loteprednol und beta2- adrenozeptor-agonisten und ihre verwendung durch inhalation zur behandlung von asthma bronchiale
EE200200404A (et) Kaltsiumdikarboksülaateetrid, nende valmistamismeetodid ja vaskulaarse haiguse ning suhkurtõve ravimine nendega
ATE386513T1 (de) Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie
DE602004007304D1 (de) Verwendung von N2O zur Behandlung von postischemischen cerebralen zellulären Beschädigungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties